Featured Story | By Nick Paul Taylor AstraZeneca is throwing open its doors to ideas from scientists near the start of their careers. Through its global R&D Postdoctoral Challenge, the Anglo-Swedish drugmaker will equip researchers to pursue novel approaches to treating diseases. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor Silence Therapeutics’ stuttering effort to generate clinical data on SLN124 in myelodysplastic syndrome (MDS) has conked out. Facing recruitment challenges, the RNAi specialist has decided to stop enrollment in the MDS arm of an early-phase clinical trial to focus on thalassemia and polycythemia vera. read more By Annalee Armstrong If at first you don’t succeed, try a sub-population analysis, the biotech playbook goes. That’s exactly what Sensorion is doing after its phase 2 hearing loss treatment—and lead program—flopped a key study in January. read more By Max Bayer The NIH has kiboshed Synairgen’s arm of the ACTIV-2 trial testing the company's SNG001 in nonhospitalized patients due to a “significant shift” in the pandemic (read: the omicron variant). The announcement from Synairgen Tuesday that recruitment was being halted came two weeks after the company first said the NIH had told it to slow its roll while the two tweaked the trial. read more By Kyle LaHucik Eiger BioPharmaceuticals' drug, licensed from Bristol Myers Squibb in 2016, halved the risk of hospitalizations or emergency room visits lasting longer than six hours in patients with COVID-19, including those with the omicron variant, in a phase 3 trial. read more By Max Bayer Shionogi's COVID-19 treatment, backed by the National Institutes of Health, is moving on to phase 3 after the FDA finalized the study design, a positive step after several clinical pauses and discontinuations have marred pandemic research funded by the NIH in March. read more By Kyle LaHucik Athenex has been trying to stem the damage since receiving a complete response letter from the FDA in February 2021 with pipeline changes and other measures. But now, it's come to layoffs and a slimmed focus on cell therapies. read more By Fraiser Kansteiner Germany will pay upward of 2.86 billion euros ($3.14 billion) to lock up local vaccine production capacity through 2029, Reuters reports, citing the country’s economy ministry. On Wednesday, the German government approved plans to sign contracts with mRNA specialists BioNTech and CureVac-GSK plus contract manufacturers Wacker and CordenPharma, Celonic and IDT. read more By Conor Hale The company’s Personalized Cancer Monitoring platform includes a set of assays that are tailored to a patient’s particular tumor. read more By Angus Liu AstraZeneca and Roche recently decided to end a patent infringement fight around Ultomiris. Now we know the price of the deal. read more By Gareth Macdonald Thermo Fisher Scientific is embarking on a clinical bioanalytical lab expansion thanks to 'buoyant' pipelines and continued demand. read more By Andrea Park In its second acquisition of the year so far, Glooko is forging ahead in its mission not only to bulk up its digital diabetes management offerings but also to expand their reach around the world. read more By Anastassia Gliadkovskaya Reputation analyzed more than 2.7 million patient reviews of the 25 largest health systems by revenue. Those with higher scores had more engagement with feedback. read more By Max Bayer Researchers from MIT and Beth Israel Deaconess Medical Center say their yeast-produced COVID-19 vax generated antibody levels comparable to J&J's one-shot jab. The team hopes the results bolster the use of the easy-to-manufacture vaccine in regions where global vaccine inequity has permeated. read more Resources Sponsored by: United Cargo The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now. Sponsored by: H1 Read why many MSLs are still challenged in developing integrated strategies to increase the volume of meaningful engagements. Download this industry report to find out what the top challenges are and suggestion strategies to solve them. Download now. Sponsored by: Medidata, a Dassault Systèmes company The landscape of clinical trials has been permanently changed. Today's trials require sponsors to modernize their use of technology and data to adapt. This eBook provides an overview of how sponsors can empower trials with real-time performance data to improve study integrity, reduce risks, optimize patient safety, and increase trial success rates. Sponsored by: Thermo Fisher Scientific Learn how to navigate the top manufacturing challenges and achieve a seamless transition from discovery to clinical manufacturing across the CAR T-cell therapy workflow. Sponsored by: Oracle Health Sciences Learn about ways to break down regulatory roadblocks and get closer to 100% clarity on regulatory positions to advance decentralized clinical trials in research. Sponsored by: Oracle Health Sciences How to overcome top challenges faced in decentralized trials. Sponsored by: Catalent How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent Biologics Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Fierce BD&L Summit for Life Sciences March 15-16, 2022 | San Francisco, CA Fierce Promotional Review Committee Compliance and Best Practices Summit April 12-14, 2022 | New Brunswick, NJ Fierce Trial Master File Summit May 2-4, 2022 | New Orleans, LA & Streaming Live Fierce Digital Pharma Engage June 14-15, 2022 | Huntington Beach, CA Fierce Pharma PR & Communications Summit West June 14-15, 2022 | Huntington Beach, CA Fierce Digital Pharma Innovation Week June 21-23, 2022 | Virtual Event Fierce MedTech Summit August 8-9, 2022 | Minneapolis, MN Promotional Review Committee Compliance and Best Practices Summit West (PRC West) September 2022 | San Diego, CA Medical Affairs Strategic Summit (MASS West) September 2022 | San Diego, CA Fierce New Product Planning Summit September 20-22, 2022 | Boston, MA Fierce Digital Pharma East October 18-20, 2022 | Philadelphia, PA & October 25-28, 2022 | Virtual Event Fierce Biotech Cell & Gene Therapy Forum October 19, 2022 | Virtual Event Fierce Pharma Marketing Awards October 19, 2022 | Philadelphia, PA Fierce Pharma Meeting Professionals Summit November 2-3, 2022 | Atlantic City, NJ Fierce European Trial Master File Summit November 14-16, 2022 | London, UK Fierce Launch Readiness for Medical Affairs & Communications Teams Summit November 30-December 1, 2022 | Virtual Event Fierce JPM Week 2023 January 2023 | San Francisco, CA & Virtual | 
